Sunday, March 22, 2026

The Latest Medical News

A Summary of The Latest Medical News: **Breakthrough Single Pill Revolutionizes HIV Treatment for Long-Term Survivors** A groundbreaking once-daily single-tablet regimen combining bictegravir and lenacapavir (BIC/LEN) offers hope for people with multidrug-resistant HIV who have endured complex multi-pill routines for decades.[1][2] **From Handfuls of Pills to One Simple Dose** Early in the HIV epidemic, patients often juggled multiple pills daily, but simpler one-pill options improved outcomes for most—until now, for those with resistant strains.[1][2] This new BIC/LEN tablet targets long-term survivors, many diagnosed 30+ years ago, who take 3 to 11 pills daily due to resistance and drug interactions.[1][2] **Stunning Results from the ARTISTRY-1 Phase 3 Trial** Led by Professor Chloe Orkin at Queen Mary University of London, the trial spanned 15 countries with over 550 participants, mostly aged around 60—the oldest median in any HIV registration trial.[1][2] Nearly **96%** maintained viral suppression (HIV below 50 copies/mL) after switching, matching the 94-96% on their prior complex regimens, with **no new resistance** reported.[1][2][3] **Safety Wins and Heart Health Boost** No major safety issues emerged, and lipid profiles improved—lowering cholesterol risks crucial for older patients with heart or kidney conditions.[1][2][3] About 80% had prior resistance, and 40% dosed multiple times daily; this switch simplifies life amid comorbidities.[1][2] **Patients Love the Convenience** Participants raved about the ease, calling it far more convenient, which boosts adherence—vital for veterans managing HIV plus age-related meds.[1][2][3] **Published Prestige and Next Steps** Results debuted February 25, 2026, at the Conference on Retroviruses and Opportunistic Infections in Denver and in *The Lancet*—signaling strong medical endorsement.[1][2][3] Ongoing trials like ARTISTRY-2 confirm long-term safety, while related research explores weekly options.[4][5] This could transform care for resilient HIV fighters, proving simpler doesn't mean less effective.[1][2] Help with your insurance? https://tally.so/r/n012P9

No comments:

Post a Comment